SEC Form 4 · accession 0000899243-15-006721
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coelho Rogerio Vivaldi
Officer — Chief Commercial Officer
Period of report
Oct 13, 2015
Accepted (ET)
Oct 14, 2015 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 13, 2015 | M | 37,333 | $7.50 | A | 42,716 | D | |
| Common Stock | Oct 13, 2015 | S | 24,000 | $48.15 | D | 18,716 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.50 | Oct 13, 2015 | M | 37,333 | D | — | Dec 1, 2024 | Common Stock | 37,333 | 165,186 | D |
Explanation of responses
- F1This option was granted on December 1, 2014 and vests over four years, with 25% of the shares underlying the option vesting on April 1, 2015 and the remainder vesting quarterly thereafter.